Institute of Hematology & Blood Diseases Hospital, China: Anemia, Hemolytic trials

The registry lists 10 Anemia, Hemolytic studies with Institute of Hematology & Blood Diseases Hospital, China as lead sponsor. 5 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 5No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic AnemiaRecruitingNCT07019038
• A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic AnemiaNot yet recruitingNCT06770504Phase 1
• CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.RecruitingNCT06733610Phase 1
• CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of TherapyRecruitingNCT06212154Phase 1
• The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic AnemiaRecruitingNCT06021977Phase 2
• CNCT19 for Patients With Autoimmune Hemolytic Anemia After Failure ≥3 Lines of Therapy.Active, not recruitingNCT06231368Phase 1
• The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic AnemiaActive, not recruitingNCT04398459Phase 2
• Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013)Status unknownNCT01760096Phase 2
• Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal HemoglobinuriaStatus unknownNCT01642979Phase 2
• Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.Status unknownNCT01579110Phase 2